Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Basilea Pharmaceutica AG
  6. Financials
    BSLN   CH0011432447

BASILEA PHARMACEUTICA AG

(BSLN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 435503574524--
Entreprise Value (EV)1 409540647606560384
P/E ratio -13,8x-22,5x-37,2x-21,7x-18,3x-91,8x
Yield ------
Capitalization / Revenue 3,28x3,74x4,50x3,84x3,48x3,07x
EV / Revenue 3,08x4,02x5,07x4,44x3,72x2,25x
EV / EBITDA -18,4x-34,7x-29,3x-51,4x12,2x3,62x
Price to Book -6,43x-5,43x-5,36x-6,29x-27,2x4,65x
Nbr of stocks (in thousands) 10 87910 73710 80311 800--
Reference price (CHF) 40,046,953,245,045,045,0
Announcement Date 02/19/201902/18/202002/16/2021---
1 CHF in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 133134128136151171
EBITDA1 -22,2-15,6-22,1-11,845,9106
Operating profit (EBIT)1 -24,1-17,2-8,22-14,228,151,0
Operating Margin -18,2%-12,8%-6,44%-10,4%18,7%29,9%
Pre-Tax Profit (EBT)1 -31,2-22,4-14,7-21,5-7,33-5,75
Net income1 -31,4-22,4-14,7-21,5-30,9-6,34
Net margin -23,7%-16,7%-11,5%-15,8%-20,5%-3,71%
EPS2 -2,89-2,08-1,43-2,07-2,46-0,49
Dividend per Share ------
Announcement Date 02/19/201902/18/202002/16/2021---
1 CHF in Million
2 CHF
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2
Net sales1 69,358,354,284,955,267,5
EBITDA ------
Operating profit (EBIT)1 12,8-21,0-15,43,60--
Operating Margin 18,5%-36,1%-28,4%4,24%--
Pre-Tax Profit (EBT)1 9,97-24,6-19,90,80--
Net income1 9,90-24,7-19,90,80--
Net margin 14,3%-42,3%-36,7%0,94%--
EPS2 0,91-2,34-1,840,07--
Dividend per Share ------
Announcement Date 08/11/202002/16/202108/17/2021---
1 CHF in Million
2 CHF
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -36,772,482,236,2-
Net Cash position1 26,1----140
Leverage (Debt / EBITDA) 1,17x-2,36x-3,28x-6,97x0,79x-1,32x
Free Cash Flow1 -79,6-64,2-56,4-43,191,1131
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 -6,21-8,63-9,93-7,15-1,659,66
Cash Flow per Share -7,31-----
Capex1 0,420,402,271,301,651,30
Capex / Sales 0,32%0,30%1,77%0,95%1,10%0,76%
Announcement Date 02/19/201902/18/202002/16/2021---
1 CHF in Million
2 CHF
Key data
Capitalization (CHF) 523 915 249
Capitalization (USD) 568 089 921
Net sales (CHF) 127 629 000
Net sales (USD) 137 686 165
Number of employees 160
Sales / Employee (CHF) 797 681
Sales / Employee (USD) 860 539
Free-Float 88,5%
Free-Float capitalization (CHF) 463 837 511
Free-Float capitalization (USD) 502 946 641
Avg. Exchange 20 sessions (CHF) 2 676 705
Avg. Exchange 20 sessions (USD) 2 887 629
Average Daily Capital Traded 0,51%
EPS & Dividend